Bilateral Anterior Subcapsular Cataract Development Following Initiation of Enfortumab Vedotin

Enfortumab vedotin is an antibody–drug conjugate that was recently granted accelerated US Food and Drug Administration approval for the treatment of locally advanced or metastatic urothelial cancer. Early clinical trials identified blurry vision, increased lacrimation and other events associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Thibodeau, Alexa, Nallasamy, Nambi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493475/
https://www.ncbi.nlm.nih.gov/pubmed/34629907
http://dx.doi.org/10.2147/IMCRJ.S324394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493475/
https://www.ncbi.nlm.nih.gov/pubmed/34629907
http://dx.doi.org/10.2147/IMCRJ.S324394

Ejemplares similares